Review Paper: Measuring outcomes for neurological disorders: A review of disease-specific health status instruments for three degenerative neurological conditions

Chronic Illness

Volumn 1, Issue 2, 2005, Pages 131-142

  Heffernan, Catherine ^a   Jenkinson, Crispin ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH STATUS; HUMAN; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PARKINSON DISEASE; QUALITY OF LIFE; REVIEW;

HEALTH STATUS; HUMANS; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; QUALITY OF LIFE;

EID: 34447095076     PISSN: 17423953     EISSN: None     Source Type: Journal    
DOI: 10.1177/17423953050010021001     Document Type: Review

References (76)

1. Jenkinson C., Fitzpatrick R., Jenkinson D. Health status measurement in neurological disorders. Abingdon: Radcliffe Medical Press, 2000.
2. Martinez-Martin P. An introduction to the concept of ‘quality of life’ in Parkinson's disease. J Neurol 1998; 245: 2-6.
3. Jenkinson C., Fitzpatrick R., Peto V. Health-related quality of life measurement in patients with Parkinson's disease. Pharmacoeconomics 1999; 15: 157-65.
4. Albrecht C. Subjective health assessment. In: Jenkinson C, ed. Measuring health and medical outcomes. London: UCL Press, 1994: 7-26.
5. Groom MJ, Lincoln NB, Francis VM, Stephan TF. Assessing mood in patients with multiple sclerosis. Clin Rehabil 2003; 17: 847-57.
6. Jenkinson C., Fitzpatrick R., Swash M., Peto V. The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe. J Neurol 2000; 247: 835-40.
7. Vickrey BG, Hays RD, Genovese BJ, Myers LW, Ellison GW. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol 1997; 50: 557-69.
8. Green C., Kiebert G., Murphy C., et al. Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis. Qual Life Res 2003; 12: 565-74.
9. Clarke S., Hickey A., O'Boyle C., Hardiman O. Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res 2001; 10: 149-58.
10. Neudert C., Wasner M., Borasio GD. Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191: 103-09.
11. Smith PS, Crossley B., Greenberg J., Wilder C., Carroll B. Agreement among three quality of life measures in patients with ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 269-75.
12. Damiano AM, Patrick DL, Guzman G. Measurement of health related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies. Med Care 1999; 37: 15-26.
13. Jenkinson C., Swash M., Fitzpatrick R., The ALS-HPS Steering Group. The European Amyotrophic Lateral Sclerosis Health Profile Study. J Neurol Sci 1998; 160: 122-26.
14. McGuire D., Garrison L., Armon C. A brief quality of life measure for ALS clinical trials based on a subset of items from the Sickness Impact Profile. J Neurol Sci 1997; 152: 18-22.
15. Goldstein LH, Atkins L., Leigh PN. Correlates of Quality of Life in people with motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3: 123-29.
16. Bromberg M., Forshew DA. Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology 2002; 58: 320-22.
17. Jenkinson C., Fitzpatrick R., Brennan C., Bromberg M., Swash M. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. J Neurol 1999; 246: 3 16-21.
18. Jenkinson C., Fitzpatrick R., Swash M. Amyotrophic lateral sclerosis/motor neurone disease. In: Jenkinson C, Fitzpatrick R, Jenkinson D, eds. Health status measurement in neurological disorders. Abingdon: Radcliffe Medical Press, 2000: 147-60.
19. Jenkinson C., Fitzpatrick R., Brennan C., Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40. Amyotroph Lateral Scler Other Motor Neuron Disord 1999; 1: 33-40.
20. Lee JN, Rigby SA, Burchardt F., Thornton EW, Dougan C., Young CA. Quality of life issues in motor neurone disease: the development and validation of a coping strategies questionnaire, the MND Coping Scale. J Neurol Sci 2001; 191: 79-85.
21. Rigby SA, Thornton EW, Tedman S., Burchardt F., Young CA, Dougan C. Quality of life assessment in MND: development of a social withdrawal scale. J Neurol Sci 1999; 169: 26-34.
22. De Boer Agem, Wijker W., Speelman JD, De Haes JCJM. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61: 70-74.
23. Welsh M., McDermott MP, Holloway RG, et al. Development and testing of the Parkinson's Disease Quality of Life Scale. Movement Disord 2003; 18: 637-45.
24. Jenkinson C., Fitzpatrick R., Peto V. The Parkinson's Disease Questionnaire. User manual for the PDQ-39, PDQ-8 and PDQ Summary Index. Oxford: Health Services Research Unit, 1998.
25. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The PDQ-8: development and validation of a short-form Parkinson's Disease Questionnaire. Psychol Health 1997; 12: 805-14.
26. Calne S., Schulzer M., Mak E., et al. Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's impact scale (PIMS). Parkinsonism Relat Disord 1996; 2: 55-61.
27. Marinus J., Ranmaker C., van Hilten JJ, Stiggelbout AM. Health related quality of life of Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002; 72: 241-48.
28. Peto V., Jenkinson C., Fitzpatrick R. Parkinson's disease. In: Jenkinson C, Fitzpatrick R, Jenkinson D, eds. Health status measurement in neurological disorders. Abingdon: Radcliffe Medical Press, 2000: 31-48.
29. Peto V., Jenkinson C., Fitzpatrick R., Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-48.
30. Peto V., Jenkinson C., Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245: 10-14.
31. Martinez-Martin P., Frades PB, Grupo Centro for Study of Movement Disorders. Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. J Neurol 1998; 245: 34-38.
32. Peto V., Fitzpatrick R., Jenkinson C. Self-reported health status and access to health services in a community sample with Parkinson's disease. Disabil Rehabil 1997; 19: 97-103.
33. Jenkinson C., Peto V., Fitzpatrick R., Greenhall R., Hyman N. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the Short-form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age Ageing 1995; 24: 505-09.
34. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997; 26: 353-57.
35. Auquier P., Sapin C., Ziegler M., et al. Validation en Francaise d'un questionnaire de qualite de vie dans le maladie de Parkinson: le Parkinson's Disease Questionnaire - PDQ-39. Rev Neurol (Paris) 2002; 158: 41-50.
36. Jenkinson C., Fitzpatrick R., Norquist JM, Findley L., Hughes K. Cross cultural validation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate and scaling assumptions in America, Canada, Japan, Italy and Spain. J Clin Epidemiol 2003; 56: 843-47.
37. La Rocca NG, Ritvo RG, Miller D., Fischer JS. Quality of life assessment in multiple sclerosis clinical trials: current status and strategies for improving multiple sclerosis clinical trial. In: Goodkin DE, Rudick RA, eds. Multiple sclerosis: advances in clinical trial design. Treatment and future perspectives. London: Springer-Verlag, 1996: 145-60.
38. Fischer JS, La Rocca NG, Miller D., Ritvo P., Andrews H., Paty D. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Multiple Sclerosis 1999; 5: 251-59.
39. Hobart J., Lamping D., Fitzpatrick R., Riazi A., Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124: 962-73.
40. Hobart JC, Riazi A., Lamping DL, Fitzpatrick R., Thompson AJ. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 2004; 8: 1-48.
41. Brownscombe IA, Laupacis A., Rice GPA, Ebers GC, Noseworthy JH. Development of a disease specific quality of life measure for multiple sclerosis. Neurology 1990; 40(Suppl.): 142.
42. Gulick EE. The self administered ADL scale for persons with multiple sclerosis. In: Waltz CF, Strickland OL, eds. Measurement of nursing outcomes, Vol. I: Measuring client outcomes. New York: Springer, 1988: 128-59.
43. Nicholl CR, Lincoln NB, Francis VM, Stephan TF. Assessing quality of life in people with multiple sclerosis. Disabil Rehabil 2001; 23: 597-603.
44. Freeman J., Hobart J., Thompson A. Does adding MS-specific items to a generic measure improve measurement? Neurology 2001; 57: 68-74.
45. Vickrey BG, Hays RD, Harooni R., Myers LW, Ellison GW. A health related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187-206.
46. Gold SM, Heesen C., Schulz H., et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Multiple Sclerosis 2001; 7: 119-30.
47. Ford HL, Gerry E., Tennant A., Whalley D., Haigh R., Johnson MH. Developing a disease specific quality of life measure for people with multiple sclerosis. Clin Rehabil 2001; 15: 247-58.
48. Stuifbergen AK, Roberts GJ. Health promotion practices of women with multiple sclerosis. Arch Phys Med Rehabil 1997; 78: 3-9.
49. Rotstein Z., Barak Y., Noy S., Achiron A. Quality of life in multiple sclerosis: development and validation of the ‘RAYS’ scale and comparison with SF-36. Int J Qual Health Care 2000; 12: 511-17.
50. Pfennings LE, Van der Ploeg HM, Cohen L., Bransen I., Polman CH, Lankhorst GJ. A health-related quality of life questionnaire for multiple sclerosis patients. Acta Neurol Scand 1999; 100: 148-55.
51. Cella DF, Dineen K., Arnason B., Reder A., Webster RA, Karabatos G. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996; 47: 129-39.
52. Nortvedt MW, Riise T. The use of quality of life measures in multiple sclerosis research. Multiple Sclerosis 2003; 9: 63-72.
53. Riazi A., Hobart JC, Lamping DL, Fitzpatrick R., Thompson AJ. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 2002; 73: 701-04.
54. Riazi A., Thompson AJ, Hobart JC. Self-efficacy predicts self-reported health status in multiple sclerosis. Multiple Sclerosis 2004; 10: 61-66.
55. McGuigan C., Hutchinson M. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry 2004; 75: 266-69.
56. Hoogervorst EL, Zwemmer JN, Jelles B., Polman CH, Uitdehaag BM. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Multiple Sclerosis 2004; 10: 569-74.
57. Martinez-Martin P., Gil-Nagel A., Morlan Gracia L, et al. Intermediate scale for assessment of Parkinson's disease. Parkinsonism Relat Disord 1995; 1: 97-102.
58. George LK, Clipp EC. Quality of life: conceptual issues and clinical implications. Neurol Rep 2000; 24: 127-32.
59. Fitzpatrick R., Hobart J., Thompson A. Multiple sclerosis. In: Jenkinson C, Fitzpatrick R, Jenkinson D, eds. Health status measurement in neurological disorders. Abingdon: Radcliffe Medical Press, 2000: 49-70.
60. Miller DM, Rudick RA, Cutter G., Baier M., Fischer JS. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Arch Neurol 2000; 57: 1319-24.
61. Jenkinson C. Evaluating the efficacy of medical treatment: possibilities and limitations. Soc Sci Med 1995; 41: 1395-401.
62. Swash M. Health outcome and quality of life measurements in amyotrophic lateral sclerosis. J Neurol 1997; 244: 25-29.
63. Prosser LA, Kuntz KM, Bar-Or A., Weinstein MC. Patient and community preferences for treatments and health states in multiple sclerosis. Multiple Sclerosis 2003; 9: 311-19.
64. Benito LJ, Morales JM, Rivera NJ, Mitchell AJ. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil 2003; 25: 1291-303.
65. Jenkinson C., McGee H. Health status measurement: a brief but critical introduction. Abingdon: Radcliffe Medical Press, 1998.
66. Lintern TC, Beaumont JG, Kenealy PM, Murrell RC. Quality of Life (QoL) in severely disabled multiple sclerosis patients: comparison of three QoL measures using multidimensional scaling. Qual Life Res 2001; 10: 371-78.
67. Schrag A., Selai C., Jahanshahi M., Quinn NP. The ED-5D a generic quality of life measure is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000; 69: 67-73.
68. Fitzpatrick R., Fletcher A., Gore S., Jones D., Spiegelhalter D., Cox D. Quality of life measures in health care. 1: Applications and issues in assessment. BMJ 1992; 305: 1074-1077.
69. Hagell P., Whalley D., McKenna SP, Lindvall O. Health status measurement in Parkinson's disease: validity of the PDQ-30 and Nottingham Health Profile. Movement Disord 2003; 18: 773-83.
70. Peto V., Jenkinson C., Fitzpatrick R. Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. Age Ageing 2001; 30: 299-302.
71. Jenkinson C., Peto V., Jones G., Fitzpatrick R. Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40). Clin Rehabil 2003; 17: 380-85.
72. Fitzpatrick R., Peto V., Jenkinson C., Greenhall R., Hyman N. Health-related quality of life in Parkinson's disease: a study of outpatient clinic attenders. Movement Disord 1997; 12: 916-22.
73. Fletcher A., Gore S., Jones D., Fitzpatrick R., Spiegelhalter D., Cox D. Quality of life measures in health care. 2: Design, analysis and interpretation. BMJ 1992; 305: 1145-1148.
74. Katsarou Z., Bostantjopoulou S., Peto V., Alevriadou A., Kiosseoglou G. Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39). Qual Life Res 2001; 10: 159-63.
75. Hagell P., McKenna SP. International use of health status questionnaires in Parkinson's disease: translation is not enough. Parkinsonism Relat Disord 2003; 10: 89-92.
76. Damiano AM, Snyder C., Strausser B., Willian MK. A review of health-related quality of life concepts and measures for Parkinson's disease. Qual Life Res 1999; 8: 235-43.